Vimarsana
Biggest News Aggregation in the World

Page 10 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

EQS-News: Immunic to Participate in Scientific Conferences in October - Vimarsana News

EQS-News: Immunic to Participate in Scientific Conferences in October

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific Conferences in October 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific Conferences in October NEW YORK, October 4, 2023 – I...

Immunic to Participate in Industry and Investor Conferences in September - Vimarsana News

Immunic to Participate in Industry and Investor Conferences in September

NEW YORK, Sept. 6, 2023 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...

EQS-News: Immunic to Participate in Industry and Investor Conferences in September - Vimarsana News

EQS-News: Immunic to Participate in Industry and Investor Conferences in September

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Investor Conferences in September 06.09.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Industry and Investor Conferences in September NEW...

Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment - Vimarsana News

Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment

  Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion...

Immunic (NASDAQ:IMUX) Now Covered by Analysts at StockNews.com - Vimarsana News

Immunic (NASDAQ:IMUX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Immunic (NASDAQ:IMUX – Free Report) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Wedbush reaffirmed an outperform rating and set a $5.00 price target on shares of Immunic in a research report on Friday, August 4th. View Our […]